http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2494760-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9b5699c43a4e2ea9cd40fdd019cf89a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40
filingDate 2012-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cbe1d5e14ed9a8edb627d126b889f33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9143d8d29c872cb7a9445918ec74698
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_119dcf4efac5c390e43190e0a46303a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_819d8507f5c3815ae34b7ee801d880ef
publicationDate 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2494760-C1
titleOfInvention Method for preparing hyperimmune serum against porcine circovirus, reproductive-respiratory syndrome and hemophilosis
abstract FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to veterinary science, namely veterinary epizootiology and immunology. The method implies as follows. The producing pigs are hyperimmunised intramuscularly in various points using monovalent inactivated porcine circovirus infection (PCVI), reproductive and respiratory syndrome (PRRS) and hemophilosis vaccines in graded doses every 7 days; that is combined with administering the preparation Gamavit for additional immunogenesis stimulation. n EFFECT: higher preventive effect and reducing length of treating of associated viral-bacterial diseases in weaned pigs due to maintaining high serum protective antibody titers to circovirus infection min 1:25600, to reproductive and respiratory syndrome min 1:12800 (in ELISA), to hemophilosis min 1:512 (in agglutination reaction). n 3 tbl, 4 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10688129-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419893-B2
priorityDate 2012-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9306211-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2357756-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0595436-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2333771-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452816548
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451560956
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613

Total number of triples: 29.